Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
News about Tenet Healthcare Corporation (NYSE: THC) centers on its role as a diversified healthcare services company with operations in general medical and surgical hospitals, ambulatory surgery centers, and healthcare business services. Tenet is headquartered in Dallas and regularly issues press releases and SEC-related announcements that provide insight into its hospital and ambulatory performance, capital structure, and strategic priorities.
Investors and healthcare observers following Tenet’s news can expect detailed quarterly earnings releases that discuss results for its Ambulatory segment, anchored by United Surgical Partners International, and its Hospital Operations and Services segment. These updates often highlight same-facility or same-hospital revenue trends, case mix, acuity, payer mix, and segment-level Adjusted EBITDA, along with commentary on operational discipline and focus areas such as higher acuity services.
Tenet’s news flow also includes announcements about upcoming earnings release dates and conference calls, participation in healthcare conferences, and descriptions of its mission to deliver quality, compassionate care. In addition, the company issues press releases related to financing activities, such as private offerings of senior secured first lien notes and senior notes used to refinance existing indebtedness, and other capital markets transactions that are later reflected in Form 8-K filings.
Sector-specific updates can feature collaborations and sponsorships that relate to clinical specialties, such as orthopaedics through partnerships involving Tenet and United Surgical Partners International. For anyone tracking THC stock, this news page provides a centralized view of Tenet’s public communications, from financial results and outlook commentary to strategic initiatives, governance developments and capital structure actions.
Tenet Healthcare (NYSE: THC) completed a transaction with CommonSpirit to resume full ownership of Conifer Health Solutions effective January 1, 2026.
Key terms include approximately $1.9 billion in payments from CommonSpirit over three years, a $540 million redemption, a reduction in redeemable noncontrolling interest of ~$885 million, and an increase to additional paid-in capital of ~$305 million. Tenet estimates 2025 Adjusted EBITDA at the upper end of its $4.47–$4.57 billion guidance. Conifer will continue serving CommonSpirit through year-end 2026. A management webcast is scheduled for February 2, 2026.
Tenet Healthcare (NYSE: THC) will report its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026.
The company will hold a conference call at 9:00 a.m. CT (10:00 a.m. ET) the same day. A live webcast and audio archive will be available in the investor relations section at www.tenethealth.com/investors.
Ryder (NYSE: R) announced the election of Tammy Romo to its board of directors, effective January 5, 2026. Romo will serve on Ryder’s Audit and Finance Committees.
Romo retired as executive vice president and chief financial officer of Southwest Airlines on April 1, 2025 after more than 30 years with the company and a decade overseeing corporate financial functions. She has served as an independent director of Tenet Healthcare (NYSE: THC) since 2015.
Tenet Healthcare (NYSE: THC) priced a private offering upsized to $2.25 billion of notes on November 3, 2025: $1.5 billion 5.500% senior secured first lien notes due November 15, 2032 and $0.75 billion 6.000% senior notes due November 15, 2033.
Closing is expected on November 18, 2025. Net proceeds, with cash on hand, will redeem all $1.5 billion outstanding 6.250% second lien notes due February 2027 and partially redeem $0.75 billion of 6.125% senior notes due October 2028. First lien notes are secured; senior notes are unsecured and will be offered only to qualified institutional buyers or outside U.S. persons under Regulation S.
Tenet Healthcare (NYSE: THC) announced private placements of $1.5 billion of senior secured first lien notes due 2032 and $0.5 billion of senior notes due 2033 to refinance $2.0 billion of outstanding notes.
The first lien notes will be guaranteed by certain subsidiaries and secured by a pledge of subsidiary ownership interests; the senior notes will be unsecured and structurally subordinated to subsidiary liabilities. Offerings are private to QIBs and non-U.S. persons under Rule 144A and Regulation S and are subject to pricing and customary closing conditions.
Tenet (NYSE: THC) reported third-quarter 2025 results with Q3 net income $342M ($3.86 diluted) and Adjusted diluted EPS $3.70, up 26.3% year-over-year. Consolidated Adjusted EBITDA was $1.099B, up 12.4% versus Q3 2024; Ambulatory Adjusted EBITDA was $492M, up 12.1%.
Year-to-date free cash flow was $2.163B, operating cash flow $2.809B, and net debt/Adjusted EBITDA improved to 2.30x. Tenet repurchased 0.6M shares for $93M in Q3 and 7.8M shares for $1.188B year-to-date. Management raised FY 2025 Adjusted EBITDA outlook to $4.47B–$4.57B (midpoint +$50M).
Tenet Healthcare (NYSE:THC) has scheduled the release of its Q3 2025 financial results for Tuesday, October 28, 2025, before market opening. The company will host a conference call at 9:30 a.m. CT (10:30 a.m. ET) to discuss the results. Investors can access both the live webcast and audio archive through Tenet's investor relations website.
Tenet Healthcare (NYSE:THC) announced its upcoming participation in the 2025 Wells Fargo Healthcare Conference. The presentation is scheduled for September 3, 2025, at 9:30 a.m. Eastern Time.
Investors can access the live webcast and audio archive through Tenet's investor relations website. The replay will remain available for 30 days following the presentation.
Tenet Healthcare (NYSE:THC) and its subsidiary USPI have been named foundational sponsors of the American Association of Orthopaedic Surgeons' (AAOS) inaugural Launchpad Program. The 20-month initiative is designed to support postgraduate year 5 (PGY5) orthopaedic surgery residents in their transition from residency to practice.
The program, launched as a pilot at the AAOS Annual Meeting in March 2025, will support three cohorts of PGY5 resident members over the next three and a half years. It focuses on fellowship navigation, preparation for American Board of Orthopaedic Surgery examinations, and building foundations for long-term success. AAOS plans to expand the program to include all PGY4 and PGY5 residents after the pilot phase.
Tenet Healthcare (NYSE:THC) reported strong Q2 2025 results with significant growth across key metrics. Net income reached $288 million ($3.14 per diluted share), while Adjusted EBITDA increased 18.6% to $1.121 billion with a 21.3% margin.
The company's Ambulatory Care segment showed robust performance with Adjusted EBITDA of $498 million, up 11.4% year-over-year. The Hospital segment delivered strong results with Adjusted EBITDA of $623 million, benefiting from favorable payer mix and higher acuity services.
Notably, the Board authorized a $1.5 billion increase to the share repurchase program. Tenet raised its FY 2025 outlook, now expecting Adjusted EBITDA between $4.40-$4.54 billion, a $395 million increase at the midpoint.
FAQ
What is the current stock price of Tenet Healthcare (THC)?
What is the market cap of Tenet Healthcare (THC)?
